» Articles » PMID: 8761302

Conditional Expression of N-myc in Human Neuroblastoma Cells Increases Expression of Alpha-prothymosin and Ornithine Decarboxylase and Accelerates Progression into S-phase Early After Mitogenic Stimulation of Quiescent Cells

Overview
Journal Oncogene
Date 1996 Aug 15
PMID 8761302
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

To elucidate the contribution of the N-Myc protein to neuroblastomas we have used a synthetic inducible expression system on the basis of the tetracycline repressor of E coli to reversibly express N-myc in a human neuroblastoma cell line in which expression of endogenous N-myc is barely detectable. Like the c-Myc protein, N-Myc up-regulates the expression of both alpha-prothymosin and ornithine decarboxylase. Induction of N-myc increases both the rate of DNA-synthesis and the proliferation rate, and shortens the G1 phase of the cell cycle. A comparison of cell populations in which the presence of N-Myc protein was restricted to different parts of G(zero)/G1 revealed that N-Myc is rate-limiting for cell cycle progression during the first 5 h after serum stimulation of quiescent cells providing direct evidence that Myc-proteins act early after mitogenic stimulation of quiescent cells.

Citing Articles

The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.

Murray J, Valli E, Milazzo G, Mayoh C, Gifford A, Fletcher J Nat Commun. 2024; 15(1):5585.

PMID: 38992040 PMC: 11239676. DOI: 10.1038/s41467-024-49871-0.


In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.

Murphy C, Devis-Jauregui L, Struck R, Boloix A, Gallagher C, Gavin C PLoS One. 2024; 19(5):e0303643.

PMID: 38809883 PMC: 11135766. DOI: 10.1371/journal.pone.0303643.


A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.

Saldana-Guerrero I, Montano-Gutierrez L, Boswell K, Hafemeister C, Poon E, Shaw L Nat Commun. 2024; 15(1):3745.

PMID: 38702304 PMC: 11068915. DOI: 10.1038/s41467-024-47945-7.


CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness.

Qin X, Lam A, Zhang X, Sengupta S, Iorgulescu J, Ni H Sci Adv. 2024; 10(11):eadh9547.

PMID: 38489372 PMC: 10942121. DOI: 10.1126/sciadv.adh9547.


Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma.

Borankova K, Krchniakova M, Leck L, Kubistova A, Neradil J, Jansson P Cell Death Dis. 2023; 14(11):747.

PMID: 37973789 PMC: 10654511. DOI: 10.1038/s41419-023-06278-x.